(OTC) derivatives, investments in debt and equity securities for the Company’s own account, bond dealing, and private repos and other investments. 2. Expenses The Company’s expenses in 2018 were Baht
expenses were 60.48 million Baht and 67.49 million Baht respectively. The expenses increased in line with the number of employees to support business expansion. The Company’s net profits were 94.55 million
by Baht 34.37 million or 7.21% from the general patients of subsidiaries. 2. Cost of hospital operations increased by Baht 41.22 million or 11.03 % due to the increasing of medical personal expenses
(29,149) (27,835) 1,314 (4.72) Gross Profit 49,306 48,521 785 1.62 Reversal of allowance for doubtful accounts 6,167 4,687 1,480 31.58 Other income 1,266 5,417 (4,151) (76.63) Profit before Expenses 56,739
million or 8.87% from the general patients of subsidiaries. 2. Cost of hospital operations increased by Baht 18.41 million or 4.44% due to the increasing of medical personal expenses and depreciation from
). Selling and administrative expenses were 10.07 million Baht and 25.68 million Baht respectively. The expenses increased in line with the number of employees to support business expansion. The Company’s net
period ended March 31, 2017 showed profit before income tax benefits (expenses) of 0.94 million Baht. When combining with income tax benefits (expenses) of 0.25 million Baht, the net profit for the period
campaign in ready to move-in projects in Q2/2020 - Selling expenses in Q2/2020 amounted 225.91 million baht compared to Selling expenses in Q2/2019 which was 219.19 million baht. Selling expenses increased
Commission Act B.E. 2535 (1992) as amended by the Securities and Exchange Commission Act (No.2) B.E. 2542 (1999) which contains certain provisions in relation to the restriction of rights and liberty of
Act (No.2) B.E. 2542 (1999) which contains certain provisions in relation to the restriction of rights and liberty of persons which Section 29 in conjunction with Section 33, Section 34, Section 41